Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 9/20 | 0.34 |
| ▸ | CES1 | P23141 | 5/20 | 0.34 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14616640 | 0.84 | EPHX1 (0.42) | EPHX1CA2ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL17577418 | 0.81 | CA1 (0.35) | EPHX1CA2CA1 | |
| SCHEMBL6308658 | 0.80 | ALDH1A1 (0.35) | CA2ALDH1A1CA12CA9CA4 | |
| SCHEMBL4209727 | 0.80 | CA2 (0.42) | EPHX1CA2ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL1618683 | 0.77 | CA2 (0.43) | EPHX1CA2ALDH1A1POLBSMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL29021584 | 0.76 | ALDH1A1 (0.36) | EPHX1CA2ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL27029988 | 0.76 | EPHX1 (0.36) | EPHX1CA2ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL25768388 | 0.76 | CA2 (0.48) | EPHX1CA2ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL14953640 | 0.75 | CA2 (0.42) | EPHX1CA2ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL17266491 | 0.75 | CA2 (0.42) | EPHX1CA2ALDH1A1POLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159569-A1 | DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2023-05-25 | — | — | US | disclosed |
| CN-104342050-B | Bonding sheet and optical component | 日东电工株式会社 | 2019-06-07 | — | — | CN | disclosed |
| US-10290900-B2 | Non-aqueous electrolytic solution and lithium ion secondary battery comprising same | NIPPON SHOKUBAI CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| CN-105368350-B | Water-dispersed acrylic class adhesive composition, adhesive phase and bonding sheet | 日东电工株式会社 | 2017-09-05 | — | — | CN | disclosed |
| CN-103930508-B | Water-dispersible type acrylic pressure-sensitive adhesive compositions and bonding sheet are peeled off again | 日东电工株式会社 | 2017-08-08 | — | — | CN | disclosed |
| CN-103890123-B | Water-dispersible type acrylic pressure-sensitive adhesive compositions and bonding sheet are peeled off again | 日东电工株式会社 | 2017-06-20 | — | — | CN | disclosed |
| US-20170117582-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM ION SECONDARY BATTERY COMPRISING SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
| US-20170117582-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM ION SECONDARY BATTERY COMPRISING SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
| CN-103958633-B | Water-dispersible acrylic pressure-sensitive adhesive composition, pressure-sensitive adhesive layer, and pressure-sensitive adhesive sheet | 日东电工株式会社 | 2017-02-15 | — | — | CN | disclosed |
| US-20100331397-A1 | 2-5A ANALOGS AND THEIR METHODS OF USE | ALIOS BIOPHARMA, INC. (US) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159569-A1 | DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF | HDAC6, PSMG3, PSMB2 | EPHX1 3929/4885CA2 3553/4885ALDH1A1 2269/4885 |
| US-20100331397-A1 | 2-5A ANALOGS AND THEIR METHODS OF USE | RNASEL, RNASE1, RNASEH1 | EPHX1 1408/4885CA2 4339/4885ALDH1A1 1405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.